Pioglitazone does not synergize with mirabegron to increase beige fat or further improve glucose metabolism

BACKGROUND Beige and brown adipose tissue (BAT) are associated with improved metabolic homeostasis. We recently reported that the β3-adrenergic receptor agonist mirabegron induced beige adipose tissue in obese insulin-resistant subjects, and this was accompanied by improved glucose metabolism. Here we evaluated pioglitazone treatment with a combination pioglitazone and mirabegron treatment and compared these with previously published data evaluating mirabegron treatment alone. Both drugs were used at FDA-approved dosages. METHODS We measured BAT by PET CT scans, measured beige adipose tissue by immunohistochemistry, and comprehensively characterized glucose and lipid homeostasis and insulin sensitivity by euglycemic clamp and oral glucose tolerance tests. Subcutaneous white adipose tissue, muscle fiber type composition and capillary density, lipotoxicity, and systemic inflammation were evaluated by immunohistochemistry, gene expression profiling, mass spectroscopy, and ELISAs. RESULTS Treatment with pioglitazone or the combination of pioglitazone and mirabegron increased beige adipose tissue protein marker expression and improved insulin sensitivity and glucose homeostasis, but neither treatment induced BAT in these obese subjects. When the magnitude of the responses to the treatments was evaluated, mirabegron was found to be the most effective at inducing beige adipose tissue. Although monotherapy with either mirabegron or pioglitazone induced adipose beiging, combination treatment resulted in less beiging than either alone. The 3 treatments also had different effects on muscle fiber type switching and capillary density. CONCLUSION The addition of pioglitazone to mirabegron treatment does not enhance beiging or increase BAT in obese insulin-resistant research participants. TRIAL REGISTRATION ClinicalTrials.gov NCT02919176. FUNDING NIH DK112282 and P20GM103527 and Clinical and Translational Science Awards grant UL1TR001998.

[1]  C. Schéele,et al.  Human Brown Adipocyte Thermogenesis Is Driven by β2-AR Stimulation. , 2020, Cell metabolism.

[2]  J. Flier.  Might β3-adrenergic receptor agonists be useful in disorders of glucose homeostasis? , 2020, The Journal of clinical investigation.

[3]  R. Bergman,et al.  Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. , 2020, The Journal of clinical investigation.

[4]  R. E. El Khouli,et al.  The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. , 2020, The Journal of clinical investigation.

[5]  J. Hansen,et al.  Beta-1 and not beta-3-adrenergic receptors may be the primary regulator of human brown adipocyte metabolism. , 2019, The Journal of clinical endocrinology and metabolism.

[6]  M. Tschöp,et al.  The role of brown and beige adipose tissue in glycaemic control. , 2019, Molecular aspects of medicine.

[7]  P. Westgate,et al.  Human adipose beiging in response to cold and mirabegron. , 2018, JCI insight.

[8]  P. Herscovitch,et al.  Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a β3-Adrenergic Receptor Agonist , 2018, Diabetes.

[9]  M. Pakzad,et al.  Rosiglitazone and a β3-Adrenoceptor Agonist Are Both Required for Functional Browning of White Adipocytes in Culture , 2018, Front. Endocrinol..

[10]  F. Villarroya,et al.  Toward an Understanding of How Immune Cells Control Brown and Beige Adipobiology. , 2018, Cell metabolism.

[11]  M. Pakzad,et al.  The PPARγ agonist rosiglitazone promotes the induction of brite adipocytes, increasing β-adrenoceptor-mediated mitochondrial function and glucose uptake. , 2018, Cellular signalling.

[12]  S. Kajimura,et al.  UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis , 2017, Nature Medicine.

[13]  P. Herscovitch,et al.  Mapping of human brown adipose tissue in lean and obese young men , 2017, Proceedings of the National Academy of Sciences.

[14]  M. Reitman.  How Does Fat Transition from White to Beige? , 2017, Cell metabolism.

[15]  Tom H. Cheung,et al.  A Molecular Switch Regulating Cell Fate Choice between Muscle Progenitor Cells and Brown Adipocytes. , 2017, Developmental cell.

[16]  P. Westgate,et al.  Mast Cells Promote Seasonal White Adipose Beiging in Humans , 2017, Diabetes.

[17]  P. Scherer,et al.  The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. , 2017, The Journal of clinical investigation.

[18]  Mitchell J. Anderson,et al.  Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans , 2017, Diabetologia.

[19]  Paul E Kinahan,et al.  Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans. , 2016, Cell metabolism.

[20]  L. Sidossis,et al.  Brown Adipose Tissue Activation Is Linked to Distinct Systemic Effects on Lipid Metabolism in Humans. , 2016, Cell metabolism.

[21]  P. Scherer,et al.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. , 2016, Cell metabolism.

[22]  Jong Hun Kim,et al.  Human ‘brite / beige’ adipocytes develop from capillary networks and their implantation improves metabolic homeostasis in mice , 2015, Nature Medicine.

[23]  F. Mottaghy,et al.  Short-term Cold Acclimation Recruits Brown Adipose Tissue in Obese Humans , 2015, Diabetes.

[24]  Bruce M. Spiegelman,et al.  Brown and Beige Fat: Physiological Roles beyond Heat Generation. , 2015, Cell metabolism.

[25]  Felix M Mottaghy,et al.  Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus , 2015, Nature Medicine.

[26]  R. Charnigo,et al.  Increasing Adipocyte Lipoprotein Lipase Improves Glucose Metabolism in High Fat Diet-induced Obesity* , 2015, The Journal of Biological Chemistry.

[27]  L. Sidossis,et al.  Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis. , 2015, The Journal of clinical investigation.

[28]  A. Doria,et al.  Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. , 2015, Cell metabolism.

[29]  B. Spiegelman,et al.  Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia , 2014, Nature.

[30]  E. Wagner,et al.  A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. , 2014, Cell metabolism.

[31]  V. Nitti,et al.  Safety and tolerability of the β3‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week randomised Phase III trials and of a 1‐year randomised Phase III trial , 2014, International journal of clinical practice.

[32]  Clark R. Andersen,et al.  Brown Adipose Tissue Improves Whole-Body Glucose Homeostasis and Insulin Sensitivity in Humans , 2014, Diabetes.

[33]  P. Seale,et al.  p107 Is a Crucial Regulator for Determining the Adipocyte Lineage Fate Choices of Stem Cells , 2014, Stem cells.

[34]  E. Kebebew,et al.  Functional thermogenic beige adipogenesis is inducible in human neck fat , 2014, International Journal of Obesity.

[35]  Alexander S. Banks,et al.  Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch , 2014, Cell.

[36]  M. Carey,et al.  Insulin Sensitizing and Anti-Inflammatory Effects of Thiazolidinediones Are Heightened in Obese Patients , 2013, Journal of Investigative Medicine.

[37]  A. Rissanen,et al.  Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humans , 2013, Obesity.

[38]  K. Clément,et al.  Fibrosis and adipose tissue dysfunction. , 2013, Cell metabolism.

[39]  P. Seale,et al.  Brown and beige fat: development, function and therapeutic potential , 2013, Nature Medicine.

[40]  Mami Matsushita,et al.  Recruited brown adipose tissue as an antiobesity agent in humans. , 2013, The Journal of clinical investigation.

[41]  Felix M Mottaghy,et al.  Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. , 2013, The Journal of clinical investigation.

[42]  I. Murano,et al.  White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma. , 2013, Biochimica et biophysica acta.

[43]  Ajit S. Divakaruni,et al.  Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier , 2013, Proceedings of the National Academy of Sciences.

[44]  O. Yamaguchi,et al.  A phase II dose-ranging study of mirabegron in patients with overactive bladder , 2013, International Urogynecology Journal.

[45]  A. Baron,et al.  Insulin resistance in the vasculature. , 2013, The Journal of clinical investigation.

[46]  D. Accili,et al.  Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ , 2012, Cell.

[47]  B. Spiegelman,et al.  Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human , 2012, Cell.

[48]  Shingo Kajimura,et al.  PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. , 2012, Cell metabolism.

[49]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[50]  B. Spiegelman,et al.  Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. , 2011, The Journal of clinical investigation.

[51]  C. Glass,et al.  Macrophages, inflammation, and insulin resistance. , 2010, Annual review of physiology.

[52]  Jan Nedergaard,et al.  Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes* , 2009, The Journal of Biological Chemistry.

[53]  Mary-Ellen Harper,et al.  Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1alpha. , 2005, Cell metabolism.

[54]  N. Petrovic,et al.  PPARγ in the control of brown adipocyte differentiation , 2005 .

[55]  G. Bray,et al.  Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. , 2005, Diabetes.

[56]  M. Lazar,et al.  Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. , 2004, The Journal of clinical investigation.

[57]  J. Hawley,et al.  Open access, freely available online Primer Skeletal Muscle Fiber Type: Influence on Contractile and Metabolic Properties , 2022 .

[58]  P. Puigserver,et al.  p38 Mitogen-Activated Protein Kinase Is the Central Regulator of Cyclic AMP-Dependent Transcription of the Brown Fat Uncoupling Protein 1 Gene , 2004, Molecular and Cellular Biology.

[59]  S. Mudaliar,et al.  Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal. , 2003, Metabolism: clinical and experimental.

[60]  J. Hardies,et al.  Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. , 2002, The Journal of clinical endocrinology and metabolism.

[61]  R. Bergman,et al.  The evolution of β‐cell dysfunction and insulin resistance in type 2 diabetes , 2002, European journal of clinical investigation.

[62]  J. Arch.  β3-Adrenoceptor agonists: potential, pitfalls and progress , 2002 .

[63]  J. Arch.  beta(3)-Adrenoceptor agonists: potential, pitfalls and progress. , 2002, European journal of pharmacology.

[64]  J. Lehmann,et al.  Activation of the Nuclear Receptor Peroxisome Proliferator-activated Receptor γ Promotes Brown Adipocyte Differentiation* , 1996, The Journal of Biological Chemistry.

[65]  J. Nedergaard,et al.  Induction of uncoupling protein in brown adipose tissue. Synergy between norepinephrine and pioglitazone, an insulin-sensitizing agent. , 1996, Biochemical pharmacology.

[66]  A. Baron,et al.  Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. , 1995, The Journal of clinical investigation.

[67]  C Bogardus,et al.  Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. , 1987, The Journal of clinical investigation.

[68]  J. Arch,et al.  Ciglitazone is not itself thermogenic but increases the potential for thermogenesis in lean mice , 1987, Bioscience reports.